Our findings provide evidence that PTTG3P facilitates CRC progression via the METTL3/PTTG3P/YAP1 axis, and PTTG3P has a potential diagnostic value, with an AUC of 0.776 (95% CI, 0.733–0.819). This evidence concerns the gene PTTG3P and colorectal carcinoma.